Physician profile
Patrick Qualtire
NPI 1326333105
$4,499.79
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,767 · 2020: $168 · 2021: $368 · 2022: $977 · 2023: $826 · 2024: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $723 · Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $722.81 |
| Food and Beverage | $498.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $1,363.58 | 2022-2023 | Fna Products |
| Wright Medical Technology, INC. | $1,191.81 | 2019-2020 | |
| Crossroads Extremity Systems, LLC | $447.92 | 2019 | |
| Zimmer Biomet Holdings, INC. | $214.58 | 2019 | |
| Novastep INC. | $182.52 | 2021 | |
| Bone Support INC. | $154.86 | 2024 | Cerament G, Ceramentbone Void Filler |
| Ossio INC | $150.00 | 2022 | |
| Stryker Corporation | $134.35 | 2021 | |
| Treace Medical Concepts, INC. | $102.36 | 2022-2023 | |
| Fusion Orthopedics USA, LLC | $82.98 | 2024 | |
| Medline Industries LP | $78.17 | 2020-2023 | |
| Arteriocyte Medical Systems, INC. | $61.59 | 2022 | |
| Polynovo North America LLC | $57.94 | 2021-2024 | Novosorb Btm |
| Tenex Health INC. | $52.35 | 2019 | |
| Flower Orthopedics Coporation | $44.12 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $38.41 | 2024 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $24.33 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $22.00 | 2022 | |
| Mimedx Group, INC. | $21.42 | 2024 | |
| Geistlich Pharma, North America, INC. | $16.92 | 2021 | |
| Kci USA, INC. | $15.68 | 2021 | |
| Smith+Nephew, INC. | $14.70 | 2024 | Renasys Touch, Pico 14, Acticoat 4" X 4" |
| Horizon Therapeutics Plc | $14.15 | 2019 | |
| Orthofix Medical, INC. | $13.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Qualtire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.